Famvir News
Most Popular Famvir Story
Roche, Teva square off in patent fight
To brand-name drug makers, Teva Pharmaceuticals is something of a Big Bad Wolf: I'll huff and I'll puff and I'll blow your patents down! Of course, Big Pharma is no defenseless little pig--just Read more...
Latest Headlines
- October 1, 2007
- September 11, 2007
- September 10, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
